Trinity immunologists find new ways to beat the 'bad guys' (w/ Video)

March 2, 2016, Trinity College Dublin
Transmission electron micrograph (TEM) of Zika virus. Credit: Cynthia Goldsmith/Centers for Disease Control and Prevention

From the current outbreak of the Zika virus to last year's Ebola, vaccines have a significant contribution to make in terms of public health. But why are they so important?

Our protects the body from pathogens. These are the 'bad guys', usually in the form of bacteria and viruses, that can cause infection.

Vaccines are like pathogen imposters - they mimic these 'bad guys' in order to provoke a response from our immune systems, remove the invader and begin the healing process.

One of the key components in a vaccine is an adjuvant, which serves to enhance our body's immune response to vaccination. Adjuvants have been around for almost a century however it is only recently that scientists are beginning to fully understand how they work.

New and improved adjuvants are needed to develop effective vaccines for TB, malaria, HIV and some cancers, diseases which require 'cell-mediated immunity' to confer protection. In order for this to happen, a better understanding of how adjuvants work is needed.

Now a discovery by immunologists at Trinity College Dublin, which has just been published in the journal Immunity, sheds light on this mystery, providing a vital clue as to the way in which adjuvants go about doing their job.

The study displayed chitosan's effectiveness as a vaccine adjuvant. Credit: Leen Tangney

Professor in Immunology Ed Lavelle, from Trinity's School of Biochemistry and Immunology, and Dr Elizabeth Carroll have uncovered the mechanism by which a promising vaccine adjuvant, chitosan, induces an immune response. The Trinity team's discovery provides a roadmap to develop vaccines that trigger 'cell-mediated immunity'.

Professor Lavelle, lead researcher on the project, commented: "Our discovery that a cationic polysaccharide can activate a DNA-sensing pathway in cells is surprising - as this pathway mainly senses pathogens - and provides exciting new perspectives for the design of for promoting cell-mediated immunity."

Explore further: Enhancing the immune response through next generation polymeric vaccine adjuvants

Related Stories

Enhancing the immune response through next generation polymeric vaccine adjuvants

April 3, 2014
Adjuvants, such as aluminum salts, have been integrated into vaccines for more than 70 years to augment the body's immune response to pathogens. Adjuvants are especially necessary to boost the immune response for subunit ...

New understanding of TB could lead to personalised treatments

February 17, 2016
Tuberculosis (TB) used to kill one in seven people around the world before the advent of antibiotics. However the increasing prevalence of multi-drug resistant TB means that doctors are running out of options in trying to ...

Research offers a new approach to improving HIV vaccines

June 4, 2015
In a scientific discovery that has significant implications for preventing HIV infections, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified a protein that could improve the body's ...

Epigenomic changes are key to innate immunological memory

August 31, 2015
A research team led by Keisuke Yoshida and Shunsuke Ishii of the RIKEN Molecular Genetics Laboratory has revealed that epigenomic changes induced by pathogen infections, mediated by a transcription factor called ATF7, are ...

Protein serves as a natural boost for immune system fight against tumors

January 30, 2014
Substances called adjuvants that enhance the body's immune response are critical to getting the most out of vaccines. These boosters stimulate the regular production of antibodies—caused by foreign substances in the body—toxins, ...

Compound boosts effect of vaccines against HIV and flu

August 26, 2012
(Medical Xpress)—Oxford University scientists have discovered a compound that greatly boosts the effect of vaccines against viruses like flu, HIV and herpes in mice.

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.